Gefitinib 250 mg is a targeted therapy drug that is used to treat non-small cell lung cancer (NSCLC). It is also commonly known as Iressa. It is a prescription drug and is only to be administered under the strict control and guidance of an oncologist or health care professional.
What is Gefitinib 250 mg?
Gefitinib 250 mg is one of the prescription drugs used to treat non-small cell lung cancer (NSCLC) in adult patients. The active ingredient is Gefitinib, with 250 mg of strength in each tablet. The Gefitinib manufacturer is American Remedies Pvt. Ltd. The medicine falls into a category of medications called epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. Tykinase 250 mg is a common treatment for selective mutations in cancer cells.
How Does Gefitinib 250 mg Work in the Body?
Gefitinib 250 mg attaches to a protein called epidermal growth factor receptor (EGFR), which is present on the surface of certain cancer cells. In some patients with non-small cell lung cancer, mutations in the EGFR gene cause this receptor to remain continuously active. This ongoing activity sends signals inside the cell that lead to uncontrolled cell growth. Gefitinib 250 mg Tab works by blocking this receptor, which interrupts the signaling process and slows or stops the growth of cancer cells.
Benefits of Gefitinib 250 mg Tablets
Gefitinib 250 mg tablets provide certain clinical advantages to patients:
- It is directed against particular EGFR mutations and can therefore be used on patients diagnosed with the help of molecular tests.
- The tablet format is easy for patients to take during long-term therapy.
- It is indicated as a first-line therapy in patients with EGFR mutation-positive NSCLC.
- It can also be incorporated into larger cancer management programs with the instruction of the physician.
Global Market & Popularity
Gefitinib 250mg Tab, a form of EGFR-targeted therapy, has been used to treat a growing number of non-small cell lung cancer cases worldwide. In the last 10 years, the EGFR inhibitor industry worldwide has made significant growth. In 2024–2025, the worldwide gefitinib market was projected to be worth between USD 1.05 billion and USD 1.2 billion. By 2033–2034, it is expected to increase at a CAGR of 6.7% to 9.5%, reaching around USD 1.85 billion to USD 2.5 billion.
Flexible Quantities to Meet Business Needs
Specialitymedz.com is a reliable Gefitinib 250 mg wholesaler and has a supply capacity of 1 million tablets per month. Your procurement needs may be on a large-scale institutional level or on a typical commercial order. Our infrastructure can handle both high and low volumes of business.
Reliable and Timely Logistics to Keep Your Business Moving
Efficient logistics ensure delivery commitment as well as establish trust. Being a responsible Gefitinib 250 mg Supplier, Specialitymedz.com has a logistical system that provides a regular and accurate delivery of orders. Our operations are harmonized with regulatory and quality regulations that refer to pharmaceutical exports. Hence, our logistics is not only effective but also ensures security, such as the integrity of the product during transit.
Can buyers inquire about product availability and lead time?
Yes, customers can make a request for in-stock levels and future lead times via Specialitymedz.com. We are a supplier of Gefitinib 250 mg, and we can supply up to 1 million tablets each month. Our team delivers suitable and prompt responses to queries revolving around supply inquiries and procurement. As a trusted supplier, Gefitinib 250mg cost is competitive when you purchase from Specialitymedz.com.
Do you accept inquiries from international buyers?
Yes, we accept inquiries from international institutional buyers worldwide as well. We have been involved in cross-border pharmaceutical business as a well-known Gefitinib 250 mg exporter. Any international order is carried out in compliance with relevant import and export rules. Our customer support team operates 24/7.
FAQs
1. Is Gefitinib 250 mg suitable for elderly patients?
Gefitinib 250 mg may be administered in old age, though the treating oncologist must decide depending on the overall health status of the patient.
2. What are the most common side effects of gefitinib?
Side effects that are frequently reported include rashes on the skin or acne, diarrhea, dry skin, nausea, loss of appetite, elevated liver enzymes, etc.
3. Are there any major drug interactions?
Yes, Gefitinib Tablet 250 mg can interact with some drugs, such as potent CYP3A4 inducers and inhibitors and drugs that influence gastric pH. Patients must discuss this with their doctors.
4. Can Gefitinib 250 mg be used as first-line therapy?
Yes, Gefitinib 250 mg is generally considered a first-line therapy in lung cancer patients with EGFR-activating mutations.
5. What is the minimum order quantity (MOQ)?
To provide flexibility, we do not have any minimum order quantity. So you can order as per your requirements.
6. Where can I buy Gefitinib 250 mg online?
Gefitinib 250 mg online purchases can be done from a reputable online exporter such as Specialitymedz.com. We can supply up to 1 million Gefitinib tablets per month.
7. Why should buyers contact Specialitymedz for supplier inquiries?
Buyers should contact Specialitymedz.com for reliable B2B pharma sourcing, verified quality, competitive pricing, and personalized support.
Leave A Review